Until now, drug formulations are still among the most important inventions, and ongoing research is being done to enhance their acceptability and efficacy in a variety of patient populations, as shown in both adults and pediatrics. Both age groups differ in a number of ways when it comes to the pharmacological element and therapy, including their aptitude for administering pharmaceuticals, how they respond to negative drug reactions, how they prefer to taste medications, and a host of other factors. Particularly, pediatrics and their pharmaceuticals require top priority due to the fact they must match and coincide with their age, size, physiological needs, and therapeutic requirements. This calls for addressing and elevating variations in these areas, particularly in pharmacokinetics, pharmacodynamics, formulation development, and regulation. This review explored these variations through a list of potentially-harmful medications for pediatrics presented in tables, as well as their uptake in adverse drug reactions than that of adults and pharmacodynamic differences, leading to the utilization of the physiologically-based Pharmacokinetic (PBPK) model for DDI prediction and evaluation model on pediatric-pharmacokinetic DDIs to assist in the safety and acceptability of commercially-available pediatric drug formulations.
Commercial food has been an essential part of any pediatric individual’s diet since the minerals and vitamins help sustain their dietary requirements and is given as early as being a newborn. However, it also contains toxicological elements which are associated with long-term bodily effects. These elements can be essential and non-essential. Essential elements found in pediatric food given as early as infancy play a part in the development of pediatric individuals. On the other hand, non-essential elements which include the heavy metals and other toxins may have long-term effects with their brain development. Pediatric individuals, but most especially newborns, infants, and young children are the most vulnerable to these contaminants since their brain and organ systems are yet undeveloped. This article aims to identify the long-term bodily effects and the risk factors of toxicological elements found in commercial pediatric food, which will either hinder or suppress the proper growth of these individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.